Access to Medicine Index

Index Identifies 5 Industry Leaders

1.	GlaxoSmithKline	(U.K.)
2.	Novo Nordisk	(Denmark)
3.	Merck & Co.	(NJ, USA)
4.	Novartis	(Switzerland)
5.	Sanofi-Aventis	(France)

Index Recognized Worldwide

News media all over the globe have covered the launch of the first Access to Medicine Index. Among the newspapers and websites that published news on the Index were the Financial Times, the International Herald tribune, the New York Times (U.S.), The Guardian (U.K.), Le Monde (France), the Financial Express (India) and De Volkskrant (The Netherlands). more >

Drug Makers Differ on Policies for Poor

The Access to Medicine Index demonstrates how major pharmaceutical companies differ strongly in their efforts to provide people in low-income countries with affordable drugs, diagnostics and vaccines.
The Index, launched June 16, presents detailed rankings and profiles of twenty of the world’s largest makers of pharmaceuticals. more >

Global Investors Support Index

Twelve institutional investors, together managing more than USD 1.2 trillion in assets, have signed an Investor Statement highlighting their interest in the Access to Medicine Index.
Major investors like Morley and Henderson Global Investors say the Index “may be useful to assess the long-term value of pharmaceutical companies.” more >

We Welcome Your Feedback

The Access to Medicine Index seeks full transparency towards all who are dedicated to the cause of improving access to medicine. We very much welcome your feedback on the Access to Medicine Index itself, on this new website and on the information the website contains.
Please use our feedback form to send us your questions or comments.

> more